Alnylam Pharmaceuticals reported $585.27M in Current Liabilities for its fourth fiscal quarter of 2020.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 105.97M 14.11M
Agios Pharmaceuticals AGIO:US $ 94.39M 24.62M
Alexion Pharmaceuticals ALXN:US $ 1624.7M 293.7M
Alnylam Pharmaceuticals ALNY:US $ 585.27M 105.03M
Amgen AMGN:US $ 11653M 1700M
Arena Pharmaceuticals ARNA:US $ 58.08M 6.18M
Arrowhead Research ARWR:US $ 25.09M 15.59M
Avrobio Inc AVRO:US $ 25.05M 9.64M
Biocryst Pharmaceuticals BCRX:US $ 105.65M 6.12M
Biomarin Pharmaceutical BMRN:US $ 492.55M 362.14M
Bluebird Bio BLUE:US $ 203.59M 6.68M
Dicerna Pharmaceuticals DRNA:US $ 177.94M 61.83M
Gw Pharmaceuticals GWPH:US $ 159.81M 19.52M
Intercept Pharmaceuticals ICPT:US $ 179.08M 15.95M
IONIS PHARMACEUT IONS:US $ 583.25M 338.68M
Mirati Therapeutics MRTX:US $ 71.47M 4.11M
Moderna Inc MRNA:US 4.39B 2.92B
Neurocrine Biosciences NBIX:US $ 186.5M 424.5M
Novartis NVS:US $ 33059M 1221M
Ptc Therapeutics PTCT:US $ 277.33M 23.51M
Regeneron Pharmaceuticals REGN:US $ 2697.4M 359.6M
Regulus Therapeutics RGLS:US $ 19.48M 1.5M
Sangamo Biosciences SGMO:US $ 143.55M 19.99M
Takeda 4502:JP Y 1804958M 95297M
Ultragenyx Pharmaceutical RARE:US $ 189.61M 11.58M
Vertex Pharmaceuticals VRTX:US $ 1877.53M 126.49M
Xencor XNCR:US $ 121.06M 50.57M
YTE INCY:US $ 631.2M 24.99M